
|Articles|March 31, 2004
Atrix granted stay in patent infringement case over LHRH therapy
The U.S. District Court for the Northern District of Illinois has issued an order granting Atrix Laboratories' motion to stay the patent infringement suit filed by TAP Pharmaceutical Products, Inc., Takeda Chemical Industries, Ltd., and Wako Pure Chemical Industries, Ltd., according to an Atrix press release.
Advertisement
Newsletter
Stay current with the latest urology news and practice-changing insights — sign up now for the essential updates every urologist needs.
Advertisement
Related Content
Latest CME
Advertisement
Advertisement
Trending on Urology Times
1
Jason Hafron, MD, recaps prostate cancer data from ESMO 2025
2
ORIC-944 shows promise in combination with ARPIs for mCRPC
3
Radioligands and ADT alternatives emerge in prostate cancer treatment
4
Beyond PSA: Jonathan Henderson, MD, on precision tools for prostate cancer
5


















